Representatives of the MIT company took part in the III All-Russian Congress with international participation "Nuclear Medicine – 2024", which was held in St. Petersburg.
The scientific program of the event covered key aspects of modern nuclear medicine, including:
- Radionuclide imaging for the diagnosis of oncological, cardiological, endocrinological, and neurological diseases.
- Radionuclide therapy and theranostics of oncological pathologies.
- Development, production, and quality control of radiopharmaceuticals.
- Preclinical studies of radiopharmaceutical agents.
- Development and creation of equipment for nuclear medicine.
- Radiation safety and legal aspects in the field of nuclear medicine.
- Training of qualified specialists for the industry.
Participation in the congress allowed for discussions on current trends, establishing new contacts, and sharing experience in the development and implementation of advanced nuclear medicine technologies.
The MIT company specializes in the comprehensive equipping of oncology and nuclear medicine centers, ensuring the supply of modern equipment and solutions.
MIT is an official distributor of leading global manufacturers, including Elekta, GE Healthcare, Comecer, Orfit, Ulrich, Sanova, PTW, LAP, and ABX advanced biochemical. A professional approach and partnership with industry leaders make MIT a reliable partner for medical institutions striving to develop and implement innovative diagnostic and treatment methods.
